Andre Henri Goy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Andre H. Goy, MD, discusses how the ZUMA-18 trial data support the benefit of earlier-line use of brexucabtagene autoleucel in mantle cell lymphoma.

Georgetown universityDistrict of columbiaUnited statesNew jerseyAndre henri goyAndreh goyLydia pfundCare transformation serviceHackensack meridian school of medicineJohn theurer cancer centerLydia pfund chairHackensack meridian school